![Ulipristal acetate / Pharmaceutical sciences / Economy of Germany / Emergency contraception / Pharmaceutical industry / Pharmacology / Hormonal contraception / Bayer Schering Pharma / Schering AG Ulipristal acetate / Pharmaceutical sciences / Economy of Germany / Emergency contraception / Pharmaceutical industry / Pharmacology / Hormonal contraception / Bayer Schering Pharma / Schering AG](https://www.pdfsearch.io/img/4e7cead7521a4c6d30b6accd68f09728.jpg)
| Document Date: 2013-01-02 09:22:07 Open Document File Size: 67,56 KBShare Result on Facebook
City Madrid / Paris / / Company HRA Pharma / Bayer Schering Pharma / Laboratorios HRA Pharma España / Schering / HRA Pharma HRA Pharma / Laboratorios HRA Pharma / / Continent Europe / / Country Germany / France / Italy / United Kingdom / Spain / / / Event FDA Phase / Company Expansion / Employment Change / / IndustryTerm healthy management / niche products / expanded corporate infrastructure / manufacturing / pharmaceutical / / MedicalCondition diseases / advanced adrenal cortical carcinoma / / MedicalTreatment emergency contraception / contraception / / Organization Women’s Health Business Unit / European Union / Republicans / / Person Ignacio Garcia / Erin Gainer / Christina Aplington Ballou / / / Position CEO / general manager / head / / Product Lysodren / NorLevo / / URL www.hra-pharma.com / /
SocialTag |